Sunday, November 1, 2026

FOMC Meeting Ahead: Will Bitcoin Survive Potential Rate Hikes?

Bitcoin fluctuates around 77,000 USD as Trump hints at a potential end to the Iran conflict by November elections.

D.O. Returns: Explore the Musical Evolution in His New Mini Album DOPAMINE!

Solo artist Do Kyung Soo returns with his fourth mini-album DOPAMINE releasing on September 8 at 6:00 p.m. (KST) across music platforms.

Galaxy S25 Fan Edition, Tab S11 Set for Debut at September Samsung Event

Samsung to unveil Galaxy S25 FE and Galaxy Tab S11 at IFA 2025, featuring advanced specs and AI integration on September 4.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.

Daewoong’s Envlo Matches Established SGLT-2 Drugs in Landmark Head-to-Head Diabetes Study

Daewoong Pharmaceutical's Envlo shows promising results in diabetes treatment, comparing favorably to existing SGLT-2 inhibitors in a clinical study.

Mediwhale Expands Global Digital Health Push With New European Certification for AI Retinal Risk Analysis

Mediwhale is advancing in digital healthcare with AI retinal analysis, securing funding, and aiming for IPO to enhance disease risk prediction.

SK Bioscience Opens Songdo Headquarters to Families as It Expands Employee-Centered Corporate Culture

SK Bioscience hosted a family open house at its new headquarters, showcasing its vision and engaging activities for employees' families.

3billion Launches Genome-Based Newborn Screening Service Overseas to Expand Early Genetic Diagnosis

3billion launches 3B-NEO, a genomic newborn screening service to identify genetic disorders in infants, enhancing early diagnosis and treatment.

Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical partners with Aribio Lab to develop and commercialize vaccines, enhancing market adoption and R&D capabilities.

Sam Chun Dang Pharm Wins EMA Approval for Phase 1 Trial of Oral Insulin Candidate SCD0503

Samchundang Pharmaceutical's oral insulin candidate 'SCD0503' received final approval for Phase 1 clinical trials from EMA.

Samsung Launches GLP-1 Muscle Loss Study With Galaxy Watch8 and Harvard-Linked Hospital

Samsung is researching muscle loss management for GLP-1 drug users, led by the Galaxy Watch 8.

Medical Innovation Committee Urges Hospitals to Embrace Decarbonization as Energy Security Threats Grow

The Healthcare Innovation Committee recommends decarbonization in healthcare to address energy security threats from the Middle East conflict.

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

Seoul St. Mary’s Hospital Performs Korea’s First Single-Port Robotic Surgery for Plantar Hyperhidrosis

Seoul St. Mary's Hospital successfully performed Korea's first robotic surgery for plantar hyperhidrosis using a single-port robotic platform.

Celltrion Moves CT-G32 Into Final Preclinical Stage as Global Obesity Trial Preparation Accelerates

Celltrion advances CT-G32, a next-gen obesity treatment, targeting multiple pathways to enhance weight loss while preserving muscle mass.

Seoul St. Mary’s Prof. Jang Ki-yuk Selected as Sole Applied Medicine Researcher in National Leader Program

Prof. Jang Ki-yuk of Seoul St. Mary's Hospital receives $5.2M for cardiovascular disease research, focusing on plaque regression.

Researchers Identify Bone Age Differences Between Limbs in Rare Pediatric Overgrowth Disorders

A study reveals children with congenital hemihypertrophy show differing bone maturation rates, impacting surgical planning for limb discrepancies.

Metavia Highlights Strong Early Weight-Loss Data for DA-1726 at EASL 2026

MetaVia's obesity treatment candidate 'DA-1726' shows safety and weight loss effects in Phase 1 trials after 54 days.

Top News

- Our Sponsors Ad -

Follow us